Davis's Drug Guide
** Update Information **
Latest Update
This resource was last updated on: 2023-8-18
New topics:
Changed topics:
- abacavir
- abaloparatide
- abemaciclib
- acalabrutinib
- acitretin
- apalutamide
- atorvastatin
- bevacizumab
- brompheniramine
- calcitriol
- calcium acetate
- clindamycin
- crisaborole
- denosumab
- dexmethylphenidate
- dextroamphetamine
- dextromethorphan
- dichlorphenamide
- didanosine
- dihydroergotamine
- dilTIAZem
- disulfiram
- DOCEtaxel
- donepezil
- dornase alfa
- doxycycline†
- doxylamine/pyridoxine
- droNABinol
- droPERidol
- dulaglutide
- dupilumab
- durvalumab
- edaravone
- efavirenz
- elbasvir/grazoprevir
- eliglustat
- eltrombopag
- eluxadoline
- elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate
- emicizumab
- encorafenib
- EPINEPHrine
- epoprostenol
- ertapenem
- eslicarbazepine
- estramustine
- eteplirsen
- ethosuximide
- ezetimibe
- fenofibrate
- fenofibric acid
- fentaNYL (transdermal)
- fexofenadine
- filgrastim
- finasteride
- fingolimod
- fluconazole
- flucytosine
- fluorouracil
- fluticasone (nasal)
- fluticasone (topical)
- fluvastatin
- follitropin beta
- formoterol
- fosamprenavir
- fosphenytoin
- gabapentin
- gefitinib
- gentamicin
- glatiramer
- glycerol phenylbutyrate
- glycopyrrolate (inhalation)
- glycopyrrolate (systemic)
- golimumab
- goserelin
- halobetasol
- heparin
- histrelin
- HYDROcodone
- hydrocortisone (systemic)
- HYDROmorphone
- hydroxychloroquine
- hydroxyurea
- ibrutinib
- IDArubicin
- idelalisib
- imiglucerase
- imiquimod
- inFLIXimab
- insulin detemir
- insulin glargine
- insulin glargine/lixisenatide
- insulin lispro
- interferon beta-1a
- interferon beta-1b
- ipilimumab
- irinotecan
- irinotecan liposomal
- isavuconazonium
- isoproterenol
- itraconazole
- ivabradine
- ivermectin
- ixabepilone
- ixazomib
- ixekizumab
- ketoconazole (topical)
- lacosamide
- lamiVUDine
- lamivudine/tenofovir disoproxil fumarate
- lanreotide
- lansoprazole
- laronidase
- lenalidomide
- lenvatinib
- leuprolide
- levocetirizine
- levomilnacipran
- levothyroxine
- lidocaine/prilocaine
- linaCLOtide
- linezolid
- liothyronine
- liraglutide
- lisdexamfetamine
- lisinopril
- lithium
- loratadine
- LORazepam
- lumacaftor/ivacaftor
- macimorelin
- mycophenolate mofetil
- omacetaxine
- rosiglitazone
- tolmetin
Citation
Vallerand, April Hazard., et al. "** Update Information **" Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/all/___Update_Information___.
Vallerand AHA, Sanoski CAC, Quiring CC. ** Update Information ** Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/all/___Update_Information___. Accessed September 22, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). ** Update Information ** In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/all/___Update_Information___
Vallerand AHA, Sanoski CAC, Quiring CC. ** Update Information ** [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 September 22]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/all/___Update_Information___.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - ** Update Information **
ID - 50998
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/all/___Update_Information___
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -